When I’m asked about the most promising areas of stem cell clinical research, cell therapy for type I diabetes is near the top including work by a biotech called ViaCyte. Other firms are in the mix too, boosting the overall odds of success in the coming decade. It’s really that promising even though there are […]
ViaCyte purchase puts Vertex in driver’s seat on stem cells for diabetes Read More »
Some unproven stem cell clinics like one called Giostar have multiple locations sprouting up. To me the concern with that spreading is the potential of multiplying risks to consumers. It can be hard to get a clear take on what these clinics are doing too. What’s in this article What is Giostar? | Giostar review |
Giostar stem cell clinic chain review, red flags, & lawsuit Read More »
How does one go about cheating death? As I get older, fighting aging seems more relevant. Having battled a potentially fatal cancer also gave me a taste of mortality. In biomedical research, it seems like living longer has become an obsession for some recently. Cheating death with cell therapies or other regenerative approaches? Could stem
Cheating death via regenerative medicine or stem cells? Read More »
The regular emails and phone calls I get from patients asking questions about stem cell therapy are a powerful reminder of the fact that research in our field can be very personal. Sometimes individuals who receive experimental stem cell therapy (or other cell therapies) and seem to have a positive outcome can end up becoming
Overplaying N=1 in the stem cell therapy world Read More »
If there’s one area of biologics where the FDA has been consistently busy lately it’s the perinatal cell therapy space. The agency has made it clear in the last year that allogeneic birth-related cell products are often drugs requiring premarket approval. This has mainly manifested at a practical enforcement level. We’ve seen actions taken in
End of FDA “grace period” impacted perinatal cell therapy biotechs Read More »
Many of you readers know tech guru Peter Diamandis for his great X PRIZE, but he’s also involved in the regenerative medicine world including a new effort called Fountain Life. Teaming up with life coach Tony Robbins and others for Fountain Life raises some red flags for me. What’s in this article Peter Diamandis and
Review of Peter Diamandis Fountain Life clinics: more than stem cell hype? Read More »
It seems like the field of cell biology has mixed feelings about fibroblasts so I’m going to start off there with the recommended reads. But first, check out our stem cell YouTube channel as we are steadily heading toward 500 subscribers and 30,000 views. Please subscribe. I’ve pasted one of our top videos below, which
Weekly reads: fibroblasts, cancer stem cells, Parkinson’s Read More »
When it comes to stem cells on Twitter and other social media, who do you follow now? Why them? Who are the top stem cell and regenerative medicine influencers to follow on Twitter and elsewhere in 2022? Stem cells on Twitter: great content amongst the noise Top stem cell and regenerative medicine influencers on Twitter.
50 influencers on stem cells on Twitter to follow in 2022 Read More »
I’m fascinated by the idea of making food from cells grown in a lab and especially the newest idea of lab-grown chocolate. While lab-grown meat has gotten the most attention, (see my recent post on test-tube meat: Not Old MacDonald’s Farm: is the future lab-grown meat?) I’d say that the coolest application of making food from
Biotech California Cultured aims to sell lab-grown chocolate Read More »
I wrote briefly a few months ago about Altos Labs. It’s a new kind of biotech institute that is focused on cellular reprogramming. Now we know much more and it’s clear this is a huge deal. What’s in this article What is Altos Labs? | Cellular rejuvenation | Reprogramming oldness | Challenges | Altos Strategies | Analysis of
All about Altos Labs and $3B cellular rejuvenation push Read More »